Valuation : Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.41M 1.32M 1.21M 2.28M 156M 2.29M 15.64M 6.06M 78.94M 6.16M 6.03M 261M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 6.98M 6.55M 5.98M 11.29M 775M 11.34M 77.5M 30.03M 391M 30.52M 29.86M 1.3B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
-3.59%-7.10%+61.60%+114.83% 1,060B
-1.15%-1.25%+52.98%+62.41% 651B
-1.09%-1.15%+26.18%+79.22% 465B
-0.72%-1.67%+39.22%+41.08% 365B
-1.02%-0.35%+23.46%+39.18% 300B
-0.40%+1.10%+2.61%+12.75% 258B
-0.43%-0.46%+52.06%+71.75% 238B
-2.47%+0.56%-16.51%-53.94% 210B
-0.46%+0.33%+29.05%+92.67% 184B
Average -10.81%-0.66%+30.07%+51.11% 414.49B
Weighted average by Cap. -0.68%-2.16%+39.74%+67.54%

Financials

2007 2008
Net sales 23.47M 20.14M 18.9M 17.27M 32.59M 2.24B 32.74M 224M 86.7M 1.13B 88.11M 86.2M 3.74B 25.96M 22.28M 20.91M 19.1M 36.05M 2.48B 36.22M 247M 95.91M 1.25B 97.47M 95.35M 4.14B
Net income -20.86M -17.9M -16.8M -15.35M -28.96M -1.99B -29.1M -199M -77.06M -1B -78.32M -76.62M -3.32B -4.01M -3.44M -3.23M -2.95M -5.56M -382M -5.59M -38.19M -14.8M -193M -15.04M -14.71M -638M
Net Debt 18.79M 16.13M 15.14M 13.83M 26.09M 1.79B 26.22M 179M 69.42M 904M 70.55M 69.02M 2.99B 6.49M 5.57M 5.23M 4.77M 9.01M 619M 9.05M 61.86M 23.97M 312M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-